Conference
Patient preferences for treatment and outcomes in hormone-sensitive prostate cancer (HSPC).
Abstract
e18757
Background: Treatment options for patients with HSPC have broadened, and data regarding patient preferences for therapies can aid in therapeutic decision-making. This study evaluated the impact of attributes associated with therapies for US patients with locally advanced prostate cancer (LAPC) or metastatic HSPC (mHSPC) from the perspective of patient preferences. Methods: An online discrete choice experiment (DCE) was …
Authors
George DJ; Ganguli A; Morgans AK; Tombal BF; Hotte SJ; Suzuki H; Bhadauria H; Oh M; Scales CD; Grover K
Volume
40
Pagination
pp. e18757-e18757
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
June 1, 2022
DOI
10.1200/jco.2022.40.16_suppl.e18757
Conference proceedings
Journal of Clinical Oncology
Issue
16_suppl
ISSN
0732-183X